Biological treatments: new weapons in the management of monogenic autoinflammatory disorders.

doi:10.1155/2013/939847

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Back to search

Article

Biological treatments: new weapons in the management of monogenic autoinflammatory disorders.

Mediators of inflammation - 1 Jan 2013

Vitale Antonio, Rigante Donato, Lucherini Orso Maria, Caso Francesco, Muscari Isabella, Magnotti Flora, Brizi Maria Giuseppina, Guerrini Susanna, Patti Maria, Punzi Leonardo, Galeazzi Mauro, Cantarini Luca

Abstract excerpt

Treatment of monogenic autoinflammatory disorders, an expanding group of hereditary diseases characterized by apparently unprovoked recurrent episodes of inflammation, without high-titre autoantibodies or antigen-specific T cells, has been revolutionized by the discovery that several of these conditions are caused by mutations in proteins involved in the mechanisms of innate immune response, including components...

Topics

Acne Vulgaris
Anemia, Dyserythropoietic, Congenital
Arthritis
Arthritis, Infectious
Biological Products
Cranial Nerve Diseases
Cryopyrin-Associated Periodic Syndromes
Familial Mediterranean Fever
Fever

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Hereditary Autoinflammatory Diseases

Humans

Immunity, Innate

Immunologic Deficiency Syndromes

Inflammation

Intracellular Signaling Peptides and Proteins

Mevalonate Kinase Deficiency

Mutation

Osteomyelitis

Source

Open in PubMed Open full text

Identifiers

PMID: 23970817
DOI: 10.1155/2013/939847
PMCID: PMC3736401

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biological treatments: new weapons in the management of monogenic autoinflammatory disorders.PMID 23970817Read ↗

Monogenic autoinflammatory diseasesSemantic proximity Read ↗

Autoinflammatory diseases in childhood, part 1: monogenic syndromesSemantic proximity Read ↗

Monogenic Autoinflammatory Diseases: State of the Art and Future PerspectivesSemantic proximity Read ↗

Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling.Semantic proximity Read ↗

[Autoinflammatory diseases].Semantic proximity Read ↗

Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach.Semantic proximity Read ↗

A practical approach to the diagnosis of autoinflammatory diseases in childhood.Semantic proximity Read ↗

New players driving inflammation in monogenic autoinflammatory diseases.Semantic proximity Read ↗

Autoinflammatory diseases: update on classification diagnosis and managementSemantic proximity Read ↗

Monogenic autoinflammatory syndromes at a dermatological level.Semantic proximity Read ↗

[The Cutting-edge of Medicine: Hereditary autoinflammatory diseases: diagnosis and management].Semantic proximity Read ↗

Inflammasomes and Childhood Autoimmune Diseases: A Review of Current Knowledge.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.